Vincent T. Ho - Concepedia

Author

Vincent T. Ho

Also Known As

Dr. Vincent T. Ho, Geraldine Pinkus, Ho, Vincent, V T Ho, V. Ho, V. T. Ho, V.T. Ho, VINCENT T. HO, Vincent B. Ho, Vincent Ho

597

Publications

26K

Citations

H-Index

144

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Massachusetts General Hospital Medical College of Wisconsin

About

Vincent T. Ho is an author at Dana-Farber Cancer Institute specializing in medicine, transplantation, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	73	4.9K
2	Health Sciences	20	23	1.4K
3	Public Health	2	2	39
4	Engineering	1	1	38
5	Natural Sciences	1	1	133

Vincent T. Ho

220

Publications

23.7K

Citations

H-Index

Page 1

	Year	Citations
Defining the Intensity of Conditioning Regimens: Working Definitions Andrea Bacigalupo, Karen K. Ballen, Doug Rizzo, Biology of Blood and Marrow Transplantation	2009	1.7K
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease John Koreth, Ken‐ichi Matsuoka, Haesook T. Kim, New England Journal of Medicine	2011	1.1K
Ipilimumab for Patients with Relapse after Allogeneic Transplantation Matthew S. Davids, Haesook T. Kim, Pavan Bachireddy, New England Journal of Medicine	2016	588
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma Christopher J. Gibson, R. Coleman Lindsley, Vatche Tchekmedyian, Journal of Clinical Oncology	2017	455
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease Ken‐ichi Matsuoka, John Koreth, Haesook T. Kim, Science Translational Medicine	2013	453
Rituximab for steroid-refractory chronic graft-versus-host disease Corey Cutler, David B. Miklos, Haesook T. Kim, Blood	2006	443
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research Sally Arai, Mukta Arora, Tao Wang, Biology of Blood and Marrow Transplantation	2014	429
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation Philippe Armand, Haesook T. Kim, Corey Cutler, Blood	2007	418
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission David B. Miklos, Haesook T. Kim, Katherine H. Miller, Blood	2004	401
ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death Mark T. Vander Lugt, Thomas Braun, Samir Hanash, New England Journal of Medicine	2013	391

Page 1